Cosmos Health Inc(COSM) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.65 | Insider Own | 23.88% | Shs Outstand | 80.7M | Perf Week | 17.97% |
| Market Cap | 0.03B | Forward P/E | 4.4 | EPS next Y | 146.67% | Insider Trans | 10.1% | Shs Float | 76.6M | Perf Month | -20.25% |
| Enterprise Value | 0.04B | PEG | - | EPS next Q | -0.04 | Inst Own | 7.19% | Short Float | 2.98% | Perf Quarter | 31.02% |
| Income | -0.02B | P/S | 0.42 | EPS this Y | 76.19% | Inst Trans | 5.06% | Short Ratio | 0.71 | Perf Half Y | -18.89% |
| Sales | 0.07B | P/B | 1.2 | EPS next 5Y | - | ROA | -39.56% | Short Interest | 2.29M | Perf YTD | -38.17% |
| Book/sh | 0.26 | P/C | 12.5 | EPS past 3/5Y | 73.29% - | ROE | -104% | 52W High | -70.39% ($1.04) | Perf Year | -65.8% |
| Cash/sh | 0.02 | P/FCF | - | Sales past 3/5Y | 9.04% 3.33% | ROIC | -101.02% | 52W Low | 90.53% ($0.16) | Perf 3Y | -70.11% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 34.05% | Gross Margin | 8.39% | Volatility(W/M) | 14.36% 12.82% | Perf 5Y | -99.7% |
| Dividend TTM | - | EV/Sales | 0.61 | Sales Y/Y TTM | 33.82% | Oper. Margin | -24.65% | ATR (14) | 0.04 | Perf 10Y | -99.81% |
| Dividend Ex-Date | - | Quick Ratio | 0.92 | EPS Q/Q | -3.25% | Profit Margin | -33.08% | RSI (14) | 51.21 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.05 | Sales Q/Q | 28.76% | SMA20 | -0.23% ($0.31) | Beta | 4.42 | Target Price | $2.95 |
| Payout | - | Debt/Eq | 0.8 | Earnings | 2026/8/19 | SMA50 | 2.77% ($0.3) | Rel Volume | 0.66 | Prev Close | $0.28 |
| Employees | 163 | LT Debt/Eq | 0.17 | EPS/Sales Surpr. | - 1.75% | SMA200 | -1.08% ($0.31) | Avg Volume(3M) | 3.21M | Price | $0.31 |
| IPO | 2010/7/23 | Option/Short | Yes/Yes | Trades | 2168 | Volume | 2,110,063 | Change | 10.95% |
💊 It is a Greece-based, vertically integrated healthcare group. The structure combines pharmaceutical and health-functional food wholesale distribution, CMO/CDMO production at its own factory (Cana Laboratories), sales of its own brands such as Sky Premium Life, and a UK-based wholesale subsidiary, making it one of the European small-cap healthcare companies with notably strong growth momentum.
Over the past 1 year, on the lower side
70% below its 1-year high.
Traded less than usual. That is 66% of its average volume.
COSM has weak earning power
Of every $100 in sales, $24.65 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +76.2% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $42. Peers typically go for $285.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -99.7%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 7.2%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #7 of 10 in the industry
Based on market cap of $31M.
FAQ
What kind of company is COSM?
COSM belongs to the Healthcare sector and operates in the Medical Distribution industry.
What is the market cap of COSM?
The market cap of COSM is approximately $31M, ranking 5,056 within its sector.
What is the 52-week high and low for COSM?
COSM has recorded a 52-week high of $1.04 and a low of $0.16.